keyword
MENU ▼
Read by QxMD icon Read
search

virus neutralisation

keyword
https://www.readbyqxmd.com/read/29151123/a-coxsackievirus-b-vaccine-protects-against-virus-induced-diabetes-in-an-experimental-mouse-model-of-type-1-diabetes
#1
Virginia M Stone, Minna M Hankaniemi, Emma Svedin, Amirbabak Sioofy-Khojine, Sami Oikarinen, Heikki Hyöty, Olli H Laitinen, Vesa P Hytönen, Malin Flodström-Tullberg
AIMS/HYPOTHESIS: Epidemiological studies suggest a role for Coxsackievirus B (CVB) serotypes in the pathogenesis of type 1 diabetes, but their actual contribution remains elusive. In the present study, we have produced a CVB1 vaccine to test whether vaccination against CVBs can prevent virus-induced diabetes in an experimental model. METHODS: NOD and SOCS1-tg mice were vaccinated three times with either a formalin-fixed non-adjuvanted CVB1 vaccine or a buffer control...
November 18, 2017: Diabetologia
https://www.readbyqxmd.com/read/29108665/evaluation-of-a-polyvalent-foot-and-mouth-disease-virus-vaccine-containing-a-saudi-95-against-field-challenge-on-large-scale-dairy-farms-in-saudi-arabia-with-the-emerging-a-asia-g-vii-viral-lineage
#2
Nicholas A Lyons, Anna B Ludi, Ginette Wilsden, Pip Hamblin, Ibrahim Ahmed Qasim, Simon Gubbins, Donald P King
In 2015, foot-and-mouth disease (FMD) viruses of the A/ASIA/G-VII lineage emerged from the Indian sub-continent to cause outbreaks in the Middle and Near East. A factor which has been proposed to have contributed to the rapid spread of this lineage is the poor in vitro vaccine-match of field isolates to vaccine strains that are commonly used in the region. This study used data from outbreaks on four large-scale dairy farms using routine vaccination in Saudi Arabia, to evaluate the impact of vaccination and learn how to manage outbreaks more effectively in this setting...
November 3, 2017: Vaccine
https://www.readbyqxmd.com/read/29102329/genetic-and-antigenic-characterization-of-serotype-o-fmd-viruses-from-east-africa-for-the-selection-of-suitable-vaccine-strain
#3
Katie Lloyd-Jones, Mana Mahapatra, Sasmita Upadhyaya, David J Paton, Aravindh Babu, Geoff Hutchings, Satya Parida
Foot-and-mouth disease (FMD) is endemic in Eastern Africa with circulation of multiple serotypes of the virus in the region. Most of the outbreaks are caused by serotype O followed by serotype A. The lack of concerted FMD control programmes in Africa has provided little incentive for vaccine producers to select vaccines that are tailored to circulating regional isolates creating further negative feedback to deter the introduction of vaccine-based control schemes. In this study a total of 80 serotype O FMD viruses (FMDV) isolated from 1993 to 2012 from East and North Africa were characterized by virus neutralisation tests using bovine antisera to three existing (O/KEN/77/78, O/Manisa and O/PanAsia-2) and three putative (O/EA/2002, O/EA/2009 and O/EA/2010) vaccine strains and by capsid sequencing...
November 1, 2017: Vaccine
https://www.readbyqxmd.com/read/29022386/bacillus-toyonensis-improves-immune-response-in-the-mice-vaccinated-with-recombinant-antigen-of-bovine-herpesvirus-type-5
#4
F D S Santos, Y A Menegon, R E A Piraine, P R C Rodrigues, R C Cunha, F P Leivas Leite
Probiotics modulate the immune response and can increase the effectiveness of vaccines. Bacillus toyonensis is widely used as a probiotic in animal feed. The aim of this study was to assess the effects of B. toyonensis administration on the immune response to an experimental recombinant vaccine against bovine herpesvirus type 5 (BoHV-5) in mice. Mice were vaccinated with BoHV-5 recombinant glycoprotein D and supplemented with the probiotic B. toyonensis in two regimes: one group received the probiotic only during seven days prior to the initial vaccination while the second group was given the probiotic throughout the experimental period of seven weeks...
October 12, 2017: Beneficial Microbes
https://www.readbyqxmd.com/read/28985239/safety-and-immunogenicity-of-rvsv%C3%AE-g-zebov-gp-ebola-vaccine-in-adults-and-children-in-lambar%C3%A3-n%C3%A3-gabon-a-phase-i-randomised-trial
#5
RANDOMIZED CONTROLLED TRIAL
Selidji T Agnandji, José F Fernandes, Emmanuel B Bache, Régis M Obiang Mba, Jessica S Brosnahan, Lumeka Kabwende, Paul Pitzinger, Pieter Staarink, Marguerite Massinga-Loembe, Verena Krähling, Nadine Biedenkopf, Sarah Katharina Fehling, Thomas Strecker, David J Clark, Henry M Staines, Jay W Hooper, Peter Silvera, Vasee Moorthy, Marie-Paule Kieny, Akim A Adegnika, Martin P Grobusch, Stephan Becker, Michael Ramharter, Benjamin Mordmüller, Bertrand Lell, Sanjeev Krishna, Peter G Kremsner
BACKGROUND: The rVSVΔG-ZEBOV-GP vaccine prevented Ebola virus disease when used at 2 × 107 plaque-forming units (PFU) in a trial in Guinea. This study provides further safety and immunogenicity data. METHODS AND FINDINGS: A randomised, open-label phase I trial in Lambaréné, Gabon, studied 5 single intramuscular vaccine doses of 3 × 103, 3 × 104, 3 × 105, 3 × 106, or 2 × 107 PFU in 115 adults and a dose of 2 × 107 PFU in 20 adolescents and 20 children. The primary objective was safety and tolerability 28 days post-injection...
October 2017: PLoS Medicine
https://www.readbyqxmd.com/read/28977009/safety-efficacy-and-immunogenicity-evaluation-of-the-sag2-oral-rabies-vaccine-in-formosan-ferret-badgers
#6
Ai-Ping Hsu, Chun-Hsien Tseng, Jacques Barrat, Shu-Hwae Lee, Yu-Hua Shih, Marine Wasniewski, Philippe Mähl, Chia-Chia Chang, Chun-Ta Lin, Re-Shang Chen, Wen-Jane Tu, Florence Cliquet, Hsiang-Jung Tsai
Since 2013, rabies cases have been reported among Formosan ferret badgers in Taiwan, and they have been shown to be the major reservoirs for Taiwanese enzootics. To control and eradicate rabies, the authorities plan to implement a vaccination programme. Before distributing live vaccines in the field, this study assessed the safety, efficacy, and immunogenicity of SAG2 vaccine on ferret badgers by direct oral instillation. After application of 109 TCID50/dose, no virus was excreted into the oral cavity 1-7 days post-application, and safety was also satisfactorily verified over a 266-day period...
2017: PloS One
https://www.readbyqxmd.com/read/28969696/efficacy-of-rabies-vaccines-in-dogs-and-cats-and-protection-in-a-mouse-model-against-european-bat-lyssavirus-type-2
#7
Tiina Nokireki, Miia Jakava-Viljanen, Anna-Maija Virtala, Liisa Sihvonen
BACKGROUND: Rabies is preventable by pre- and/or post-exposure prophylaxis consisting of series of rabies vaccinations and in some cases the use of immunoglobulins. The success of vaccination can be estimated either by measuring virus neutralising antibodies or by challenge experiment. Vaccines based on rabies virus offer cross-protection against other lyssaviruses closely related to rabies virus. The aim was to assess the success of rabies vaccination measured by the antibody response in dogs (n = 10,071) and cats (n = 722), as well as to investigate the factors influencing the response to vaccination when animals failed to reach a rabies antibody titre of ≥ 0...
October 2, 2017: Acta Veterinaria Scandinavica
https://www.readbyqxmd.com/read/28965516/high-prevalence-of-seoul-hantavirus-in-a-breeding-colony-of-pet-rats
#8
L M McELHINNEY, D A Marston, K C Pounder, H Goharriz, E L Wise, J Verner-Carlsson, D Jennings, N Johnson, A Civello, A Nunez, T Brooks, A C Breed, J Lawes, Å Lundkvist, C A Featherstone, A R Fooks
As part of further investigations into three linked haemorrhagic fever with renal syndrome (HFRS) cases in Wales and England, 21 rats from a breeding colony in Cherwell, and three rats from a household in Cheltenham were screened for hantavirus. Hantavirus RNA was detected in either the lungs and/or kidney of 17/21 (81%) of the Cherwell rats tested, higher than previously detected by blood testing alone (7/21, 33%), and in the kidneys of all three Cheltenham rats. The partial L gene sequences obtained from 10 of the Cherwell rats and the three Cheltenham rats were identical to each other and the previously reported UK Cherwell strain...
October 2, 2017: Epidemiology and Infection
https://www.readbyqxmd.com/read/28956525/emerging-arboviruses-in-quebec-canada-assessing-public-health-risk-by-serology-in-humans-horses-and-pet-dogs
#9
J P Rocheleau, P Michel, L R Lindsay, M Drebot, A Dibernardo, N H Ogden, A Fortin, J Arsenault
Periodic outbreaks of West Nile virus (WNV), Eastern equine encephalitis virus (EEEV) and to a lesser extent, California serogroup viruses (CSGV), have been reported in parts of Canada in the last decade. This study was designed to provide a broad assessment of arboviral activity in Quebec, Canada, by conducting serological surveys for these arboviruses in 196 horses, 1442 dogs and 485 humans. Sera were screened by a competitive enzyme linked immunosorbent assay and positive samples confirmed by plaque reduction neutralisation tests...
October 2017: Epidemiology and Infection
https://www.readbyqxmd.com/read/28915240/improved-reliability-of-serological-tools-for-the-diagnosis-of-west-nile-fever-in-horses-within-europe
#10
Cécile Beck, Steeve Lowenski, Benoit Durand, Céline Bahuon, Stéphan Zientara, Sylvie Lecollinet
West Nile Fever is a zoonotic disease caused by a mosquito-borne flavivirus, WNV. By its clinical sensitivity to the disease, the horse is a useful sentinel of infection. Because of the virus' low-level, short-term viraemia in horses, the primary tools used to diagnose WNV are serological tests. Inter-laboratory proficiency tests (ILPTs) were held in 2010 and 2013 to evaluate WNV serological diagnostic tools suited for the European network of National Reference Laboratories (NRLs) for equine diseases. These ILPTs were designed to evaluate the laboratories' and methods' performances in detecting WNV infection in horses through serology...
September 2017: PLoS Neglected Tropical Diseases
https://www.readbyqxmd.com/read/28894111/induction-of-high-titred-non-neutralising-antibodies-by-self-adjuvanting-peptide-epitopes-derived-from-the-respiratory-syncytial-virus-fusion-protein
#11
Noushin Jaberolansar, Keith J Chappell, Daniel Watterson, Imogen M Bermingham, Istvan Toth, Paul R Young, Mariusz Skwarczynski
Respiratory syncytial virus (RSV) causes severe lower respiratory tract illness in infants and young children. The significant morbidity and mortality rates associated with RSV infection make an effective RSV vaccine development a priority. Two neutralising antibody binding sites, Ø and II, located on the pre-fusion RSV F glycoprotein are prime candidates for epitope-focused vaccine design. We report on a vaccine strategy that utilises a lipid core peptide (LCP) delivery system with self-adjuvanting properties in conjunction with either the antigenic site Ø or II (B cell epitopes) along with PADRE as a T helper cell epitope...
September 11, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28880111/anti-ndv-activity-of-9-oxo10-11-dehydroageraphorone-extracted-from-eupatorium-adenophorum-spreng-in-vitro
#12
Ruiguang Xu, Jiahua Weng, Liwen Hu, Guangneng Peng, Zhihua Ren, Junliang Deng, Yan Jia, Chengmin Wang, Hongxuan He, Yanchun Hu
The purpose of this study was to investigate the anti-Newcastle disease virus (NDV) activities of 9-oxo-10,11-dehydroageraphorone (euptox A) from Eupatorium adenophorum Spreng (E. adenophorum) in vitro. NDV infection of chicken embryo fibroblasts (CEFs) was performed. Cytotoxicities and antiviral activities of euptox A was assessed by the MTT method. The interaction of NDV with cell membrane protein was detected by virus overlay protein binding assay (VOPBA). The expression levels of NDV genes in CEFs was tested by RTFQ PCR...
September 7, 2017: Natural Product Research
https://www.readbyqxmd.com/read/28871961/genetic-epidemiology-of-dengue-viruses-in-phase-iii-trials-of-the-cyd-tetravalent-dengue-vaccine-and-implications-for-efficacy
#13
Maia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, Trung Vu Tuan, Bridget Wills, Matthew Bonaparte, Diane van der Vliet, Edith Langevin, Margarita Cortes, Betzana Zambrano, Corinne Dunod, Anh Wartel-Tram, Nicholas Jackson, Cameron P Simmons
This study defined the genetic epidemiology of dengue viruses (DENV) in two pivotal phase III trials of the tetravalent dengue vaccine, CYD-TDV, and thereby enabled virus genotype-specific estimates of vaccine efficacy (VE). Envelope gene sequences (n = 661) from 11 DENV genotypes in 10 endemic countries provided a contemporaneous global snapshot of DENV population genetics and revealed high amino acid identity between the E genes of vaccine strains and wild-type viruses from trial participants, including at epitope sites targeted by virus neutralising human monoclonal antibodies...
September 5, 2017: ELife
https://www.readbyqxmd.com/read/28830430/tick-borne-encephalitis-in-a-naturally-infected-sheep
#14
Brigitte Böhm, Benjamin Schade, Benjamin Bauer, Bernd Hoffmann, Donata Hoffmann, Ute Ziegler, Martin Beer, Christine Klaus, Herbert Weissenböck, Jens Böttcher
BACKGROUND: Tick-borne encephalitis (TBE) is the most important viral tick borne zoonosis in Europe. In Germany, about 250 human cases are registered annually, with the highest incidence reported in the last years coming from the federal states Bavaria and Baden-Wuerttemberg. In veterinary medicine, only sporadic cases in wild and domestic animals have been reported; however, a high number of wild and domestic animals have tested positive for the tick-borne encephalitis virus (TBEV) antibody...
August 22, 2017: BMC Veterinary Research
https://www.readbyqxmd.com/read/28797124/preclinical-development-of-a-vaccine-against-oligomeric-alpha-synuclein-based-on-virus-like-particles
#15
Marika Doucet, Aadil El-Turabi, Franziska Zabel, Benjamin H M Hunn, Nora Bengoa-Vergniory, Milena Cioroch, Mauricio Ramm, Amy M Smith, Ariane Cruz Gomes, Gustavo Cabral de Miranda, Richard Wade-Martins, Martin F Bachmann
Parkinson's disease (PD) is a progressive and currently incurable neurological disorder characterised by the loss of midbrain dopaminergic neurons and the accumulation of aggregated alpha-synuclein (a-syn). Oligomeric a-syn is proposed to play a central role in spreading protein aggregation in the brain with associated cellular toxicity contributing to a progressive neurological decline. For this reason, a-syn oligomers have attracted interest as therapeutic targets for neurodegenerative conditions such as PD and other alpha-synucleinopathies...
2017: PloS One
https://www.readbyqxmd.com/read/28794181/neutralization-assay-for-zika-and-dengue-viruses-by-use-of-real-time-pcr-based-endpoint-assessment
#16
Heather L Wilson, Thomas Tran, Julian Druce, Myrielle Dupont-Rouzeyrol, Michael Catton
The global spread and infective complications of Zika virus (ZKV) and dengue virus (DENV) have made them flaviviruses of public health concern. Serological diagnosis can be challenging due to antibody cross-reactivity, particularly in secondary flavivirus infections or when there is a history of flavivirus vaccination. The virus neutralization assay is considered to be the most specific assay for measurement of anti-flavivirus antibodies. This study describes an assay where the neutralization endpoint is measured by real-time PCR, providing results within 72 h...
October 2017: Journal of Clinical Microbiology
https://www.readbyqxmd.com/read/28789849/protective-effects-of-high-potency-fmdv-o1-manisa-monovalent-vaccine-in-cattle-challenged-with-fmdv-o-skr-2010-at-7-or-4-days-post-vaccination
#17
Jacquelyn Horsington, Claudia Beascoechea Perez, Eduardo Maradei, Sabrina Galdo Novo, Jose L Gonzales, Nagendrakumar B Singanallur, Paula Bonastre, Wilna Vosloo
Serotype O foot-and-mouth disease (FMD) virus belonging to the SEA topotype continues to be a significant problem in the Eastern Asia region, with outbreaks in Japan and South Korea resulting in the culling of over 3.5 million cattle and pigs in recent years. High-potency O1 Manisa vaccine was previously shown to provide protection in cattle 21days post vaccination (dpv) following challenge with a representative virus, O/SKR/2010. This study tested the ability of the O1 Manisa vaccine to protect cattle from infection and disease with the O/SKR/2010 virus within just 4 or 7days post vaccination...
August 5, 2017: Vaccine
https://www.readbyqxmd.com/read/28780422/efficacy-of-a-high-potency-o1-manisa-monovalent-vaccine-against-heterologous-challenge-with-foot-and-mouth-disease-virus-of-o-sea-mya-98-lineage-in-sheep
#18
N B Singanallur, J M Pacheco, J Arzt, C Stenfeldt, G T Fosgate, L Rodriguez, W Vosloo
Potency tests for commercial oil-adjuvanted foot-and-mouth disease (FMD) vaccines are usually carried out in cattle, using a full dose (2 ml) of vaccine and homologous virus challenge. However, in sheep the recommended vaccine dose is half of the cattle dose (1 ml) and most vaccines have not been potency tested for this species, especially with heterologous viruses. To determine the efficacy of a high potency (>6PD50) FMD virus (FMDV) O1Manisa vaccine in sheep, we carried out a study using a heterologous FMDV (FMDV O/SKR/2010 - Mya-98 strain) challenge...
August 3, 2017: Antiviral Research
https://www.readbyqxmd.com/read/28767977/clinical-and-serological-tests-for-arboviruses-in-free-living-domestic-pigeons-columba-livia
#19
Bruna Alves Ramos, Jannifer Oliveira Chiang, Lívia Carício Martins, Liliane Leal das Chagas, Franko de Arruda E Silva, Milene Silveira Ferreira, Maria Nazaré Oliveira Freitas, Bianca Nascimento de Alcantara, Sandro Patroca da Silva, Stefânia Araújo Miranda, Barbara Alves Sepulvreda, Layna Thayssa Guimarães Corrêa, Andréa Maria Góes Negrão, Pedro Fernando da Costa Vasconcelos, Alexandre do Rosário Casseb
BACKGROUND: In this study, we evaluated the role of free-living domestic pigeons (Columba livia) as a reservoir of arboviruses in the city of Belém, state of Pará, Brazil. We investigated the presence of antibodies against the most prevalent arboviruses. OBJECTIVES: This study was aimed at evaluating some clinical and physical parameters of domestic pigeons, including the presence of antibodies to Amazon-endemic arboviruses. METHODS: Eighty-five healthy pigeons were captured in Mangal das Garças Park, in Belém, and were bled...
August 2017: Memórias do Instituto Oswaldo Cruz
https://www.readbyqxmd.com/read/28757043/a-large-scale-serological-survey-of-akabane-virus-infection-in-cattle-yak-sheep-and-goats-in-china
#20
Jidong Wang, Kim R Blasdell, Hong Yin, Peter J Walker
Akabane virus (AKAV) is a member of the Simbu serogroup, classified in the genus Orthobunyavirus, family Bunyaviridae. AKAV infection can cause abortion, stillbirth, and congenital arthrogryposis and hydranencephaly in cattle and sheep. The distribution and prevalence of AKAV infection in China is still unknown. A total of 2731 sera collected from 2006 to 2015 in 24 provinces of China from cattle, sheep, goats and yak were examined by serum neutralisation test. The overall seroprevalence rates for AKAV antibodies were 21...
August 2017: Veterinary Microbiology
keyword
keyword
120066
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"